Actinium Pharmaceuticals


Actinium Pharmaceuticals is focused on developing innovative targeted radioimmunotherapies for the treatment of advanced cancers.

Industries

Employees

11-50

Links


Org chart

Sandesh Seth
CEO & Chairman
Collapse
Jenny Hsieh
Chief Strategy Officer
Paul Diamond
VP, Patent & Legal Counsel
Jenny H.
Chief Strategy Officer
Lynn Bodarky
Chief Business Officer
Peter James Baker
Director Drug Substance / Drug Product Manufacturing
Jason Li
Associate Scientist
Sumit Mukherjee
Manager Of In Vivo Biology
Mary Mei Chen
VP, Clinical Development
Helen Kotanides
VP, Translational Research & Preclinical Development
Colin Campbell
Sr Director, Head Of Manufacturing Sciences And Technology

Board & advisors

C. David Nicholson
Lead Independent Director
Jeffrey W. Chell
Board Member